HWM
ELGX

HighMark Wealth Management’s Endologix Inc ELGX Stock Holding History

HighMark Wealth Management’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,500
Closed -$3K – 438
2019
Q4 		$3K Buy
+2,500
New +$6.99K ﹤0.01% 339

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

HighMark Wealth Management's ELGX Position: Q1 2020 in Review

HighMark Wealth Management sold out of Endologix Inc (ELGX) in Q1 2020, closing a stake of 2,500 shares — an estimated $3K sold.

HighMark Wealth Management first reported a position in ELGX in Q4 2019 and held it in 1 quarter. The position peaked at $3K in Q4 2019. 50 funds tracked by Wall St. Rank hold ELGX as of Q1 2020.

  • HighMark Wealth Management reported no remaining Endologix Inc position as of Q1 2020 after selling out during the quarter.
  • HighMark Wealth Management sold 2,500 Endologix Inc shares in Q1 2020, an estimated $3K.
  • HighMark Wealth Management first reported a position in Endologix Inc in Q4 2019 and held it in 1 quarter.
  • HighMark Wealth Management's Endologix Inc position peaked at $3K in Q4 2019.
  • 50 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2020.

Based on HighMark Wealth Management's 13F filing for Q1 2020, filed 30 Apr 2020.